Fredun Pharmaceuticals Ltd

NSE: FREDUN · BSE: 539730 · Pharmaceuticals & Biotechnology · 31 announcements

Share price: ₹1,476.05
Market cap: ₹2,109 Cr
Revenue (annual): ₹635.5 Cr
Net profit (annual): ₹32.62 Cr
P/E (TTM): 48.1×Sector 47.3×
Promoter holding: 44.57%+0.40% QoQ
FII holding: 1.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 5 Financial Results 4 Other Announcement 3 Earnings Call 3 Results Update 2 Bonus Issue 2 Annual General Meeting 2 Acquisition 2 Product Launch 1 Dividend 1 Debt & Borrowing 1 Capacity Expansion 1 Business Update 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 Apr 2026 11:24 IST BSE

Capacity ExpansionAlfa Alert

Fredun Pharmaceuticals Capacity Expansion

Fredun Pharmaceuticals announced a new 40,000 sq. ft. manufacturing facility in Palghar, Maharashtra, its fifth unit. The plant, expected to be operational by October 2026, will support veterinary and nutraceutical production. A further 50,000 sq. ft. expansion is also planned, strengthening the company's manufacturing footprint and scalability to meet domestic and international demand.

Execution: expected to be operational by October 2026

Read the filing ↗